Overview

Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

This is a Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma.

Phase:

Phase 3

Details

Lead Sponsor:

King Faisal Specialist Hospital & Research Center

Collaborator:

Radiation Therapy Oncology Group

Treatments:

Dacarbazine
Temozolomide